Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: Effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviour

被引:8
|
作者
Skutella, T
Schwarting, RKW
Huston, JP
Sillaber, I
Probst, JC
Holsboer, F
Spanagel, R
机构
[1] MAX PLANCK INST PSYCHIAT,DEPT NEUROENDOCRINOL,D-80804 MUNICH,GERMANY
[2] UNIV DUSSELDORF,INST PHYSIOL PSYCHOL 1,D-40225 DUSSELDORF,GERMANY
关键词
antisense targetting; nigrostriatal pathway; turning behaviour; in vivo microdialysis; rat;
D O I
10.1111/j.1460-9568.1997.tb01392.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Modulation of the transcriptional message of tyrosine hydroxylase was investigated in vivo in the rat nigrostriatal dopamine system with unmodified antisense oligodeoxynucleotide, mismatch oligodeoxynucleotide or vehicle controls. Oligodeoxynucleotide was infused (0.5 mu g/0.5 mu l/h) unilaterally into the substantia nigra by an osmotic minipump system over 14 days. The presence of oligodeoxynucleotide in the brain was verified by in situ hybridization and fluorescence labelling. Animals treated with unmodified antisense oligodeoxynucleotide showed ipsilateral turning behaviour when challenged systemically with the indirect dopamine agonist amphetamine, whereas mismatch- and vehicle-infused rats showed no such behavioural asymmetries. In the substantia nigra, antisense treatment had no effects on tyrosine hydroxylase mRNA, but it led to a reduction in tyrosine hydroxylase protein content. Tissue levels of dopamine, measured in postmortem tissue punches of the neostriatum and substantia nigra, were reduced in the oligodeoxynucleotide-treated hemisphere. Furthermore, basal extracellular levels of dopamine, monitored by in vivo microdialysis, were also lower in the neostriatum ipsilateral to antisense infusion and showed a weaker response to an amphetamine challenge when compared with the contralateral side. These effects were not observed after infusion of mismatch oligodeoxynucleotide or vehicle into the substantia nigra, Finally, the GABAergic enzyme glutamate decarboxylase was not affected in the antisense-treated substantia nigra, indicating that non-specific damage in this area was not caused by this treatment. Our results indicate that antisense oligodeoxynucleotide treatment against tyrosine hydroxylase in the substantia nigra has behavioural and neurochemical effects that are comparable with known actions of dopamine neurotoxins, which are conventional pharmacological tools for the depletion of dopamine, Furthermore, our data show the potential of antisense targetting to reveal new relationships between neurotransmitter-related enzymes and behavioural parameters, because the possibility of selectively and discretely manipulating tyrosine hydroxylase function is likely to produce new insights into the physiological and behavioural functions of the dopaminergic nigrostriatal system.
引用
收藏
页码:210 / 220
页数:11
相关论文
共 50 条
  • [1] Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra
    Salvatore, MF
    Zhang, JL
    Large, DM
    Wilson, PE
    Gash, CR
    Thomas, TC
    Haycock, JW
    Bing, GY
    Stanford, JA
    Gash, DM
    Gerhardt, GA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 90 (01) : 245 - 254
  • [2] Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat
    delaCruz, CP
    Revilla, E
    Venero, JL
    Ayala, A
    Cano, J
    Machado, A
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (01) : 53 - 61
  • [3] Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra
    Soriano, MA
    Justicia, C
    Ferrer, I
    Rodriguez-Farre, E
    Planas, AM
    [J]. NEUROBIOLOGY OF DISEASE, 1997, 4 (05) : 376 - 385
  • [4] OPIATE-RECEPTORS IN SUBSTANTIA NIGRA - ROLE IN THE REGULATION OF STRIATAL TYROSINE-HYDROXYLASE ACTIVITY
    GALE, K
    MORONI, F
    KUMAKURA, K
    GUIDOTTI, A
    [J]. NEUROPHARMACOLOGY, 1979, 18 (04) : 427 - 430
  • [5] INDUCTION OF TYROSINE-HYDROXYLASE IN THE RAT SUBSTANTIA-NIGRA BY LOCAL INJECTION OF FORSKOLIN
    LEVIEL, V
    GUIBERT, B
    MALLET, J
    FAUCONBIGUET, N
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 30 (02) : 427 - 432
  • [6] STRIATAL INJECTION OF NEUROTENSIN INCREASES TYROSINE-HYDROXYLASE MESSENGER-RNA IN SUBSTANTIA-NIGRA
    BURGEVIN, MC
    LADURON, PM
    QUARTERONNET, D
    CHEVET, T
    CASTEL, MN
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 668 : 311 - 313
  • [7] DOPAMINE AUTORECEPTORS MODULATE THE PHOSPHORYLATION OF TYROSINE-HYDROXYLASE IN RAT STRIATAL SLICES
    SALAH, RS
    KUHN, DM
    GALLOWAY, MP
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (05) : 1517 - 1522
  • [8] CONVERGENT REGULATION BY CILIARY NEUROTROPHIC FACTOR AND DOPAMINE OF TYROSINE-HYDROXYLASE EXPRESSION IN CULTURES OF RAT SUBSTANTIA-NIGRA
    MAGAL, E
    BURNHAM, P
    VARON, S
    LOUIS, JC
    [J]. NEUROSCIENCE, 1993, 52 (04) : 867 - 881
  • [9] Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine
    Corso, TD
    Torres, G
    Goulah, C
    Roy, I
    Gambino, AS
    Nayda, J
    Buckley, T
    Stachowiak, EK
    Bergey, EJ
    Pudavar, H
    Dutta, P
    Bloom, DC
    Bowers, WJ
    Stachowiak, MK
    [J]. MOLECULAR BRAIN RESEARCH, 2005, 139 (02): : 361 - 366
  • [10] Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine
    RodriguezGomez, JA
    RomeroRamos, M
    Vizuete, ML
    Venero, JL
    Cano, J
    Machado, A
    [J]. MOLECULAR PHARMACOLOGY, 1997, 52 (04) : 641 - 647